• to lower the risk of really serious cardiovascular (coronary heart and blood vessel) difficulties in Grownups with type 2 diabetes and cardiovascular diseaseIn Oct 2024, Novo Nordisk released a analyze on scientific journal Character a couple of novel glucose-delicate insulin NNC2215 which can decrease the potential risk of hypoglycemia in anim